Association of tramadol with all-cause mortality, cardiovascular diseases, venous thromboembolism, and hip fractures among patients with osteoarthritis: a population-based study

BACKGROUND: The use of tramadol among osteoarthritis (OA) patients has been increasing rapidly around the world, but population-based studies on its safety profile among OA patients are scarce. We sought to determine if tramadol use in OA patients is associated with increased risks of all-cause mort...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lingyi, Marozoff, Shelby, Lu, Na, Xie, Hui, Kopec, Jacek A., Cibere, Jolanda, Esdaile, John M., Aviña-Zubieta, J. Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996663/
https://www.ncbi.nlm.nih.gov/pubmed/35410440
http://dx.doi.org/10.1186/s13075-022-02764-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996663/
https://www.ncbi.nlm.nih.gov/pubmed/35410440
http://dx.doi.org/10.1186/s13075-022-02764-3

Ejemplares similares